We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$70.1B
AUM Growth
-$3.23B
Cap. Flow
+$3.3B
Cap. Flow %
4.71%
Top 10 Hldgs %
10.04%
Holding
5,020
New
596
Increased
1,359
Reduced
1,925
Closed
795

Sector Composition

Rank Sector Weight
1 Communication Services 9.3%
2 Healthcare 8.21%
3 Consumer Discretionary 8.05%
4 Energy 7.7%
5 Technology 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBC icon
2726
PUT
RBC Bearings
RBC
$16.3B
$1.38M ﹤0.01%
21,600
-5,000
-19% -$327K
DAKT icon
2727
CALL
Daktronics
DAKT
$942M
$1.37M ﹤0.01%
95,500
ECHO
2728
PUT
DELISTED
Echo Global Logistics, Inc.
ECHO
$1.37M ﹤0.01%
+75,000
New +$1.38M
NJ
2729
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$1.37M ﹤0.01%
89,356
-33,278
-27% -$475K
GSIG
2730
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
$1.37M ﹤0.01%
105,050
-24,684
-19% -$290K
PPC icon
2731
Pilgrim's Pride
PPC
$7.45B
$1.37M ﹤0.01%
65,485
+38,185
+140% +$657K
APOL
2732
PUT
DELISTED
Apollo Education Group Inc Class A
APOL
$1.37M ﹤0.01%
40,000
NVS icon
2733
CALL
Novartis
NVS
$299B
$1.37M ﹤0.01%
17,968
-42,408
-70% -$3.09M
FOLD
2734
DELISTED
Amicus Therapeutics
FOLD
$1.37M ﹤0.01%
660,790
+53,742
+9% +$134K
UTL icon
2735
Unitil
UTL
$981M
$1.36M ﹤0.01%
41,551
-6,376
-13% -$198K
CCOI icon
2736
Cogent Communications
CCOI
$515M
$1.36M ﹤0.01%
38,377
+3,090
+9% +$121K
RALY
2737
DELISTED
RALLY SOFTWARE DEV CORP
RALY
$1.36M ﹤0.01%
+101,926
New +$2.03M
SUPN icon
2738
Supernus Pharmaceuticals
SUPN
$2.61B
$1.36M ﹤0.01%
+152,442
New +$1.4M
THO icon
2739
CALL
Thor Industries
THO
$4.05B
$1.36M ﹤0.01%
22,300
-27,900
-56% -$1.55M
AYR
2740
DELISTED
Aircastle Ltd
AYR
$1.36M ﹤0.01%
70,245
+12,409
+21% +$236K
HZNP
2741
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.36M ﹤0.01%
+90,000
New +$1.02M
ESV
2742
DELISTED
Ensco Rowan plc
ESV
$1.36M ﹤0.01%
6,443
-2,344
-27% -$490K
GPX
2743
DELISTED
GP Strategies Corp.
GPX
$1.36M ﹤0.01%
49,926
-23,120
-32% -$654K
STSA
2744
DELISTED
STERLING FINL CORP (WA) COM NEW
STSA
$1.36M ﹤0.01%
40,763
-12,461
-23% -$403K
ROCK icon
2745
Gibraltar Industries
ROCK
$1.38B
$1.35M ﹤0.01%
71,827
+4,939
+7% +$89.6K
UIL
2746
DELISTED
UIL HOLDINGS
UIL
$1.35M ﹤0.01%
+36,757
New +$1.38M
ALNY icon
2747
PUT
Alnylam Pharmaceuticals
ALNY
$32B
$1.35M ﹤0.01%
20,100
FRTX
2748
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1.35M ﹤0.01%
332
+318
+2,271% +$1.42M
COO icon
2749
Cooper Companies
COO
$14.2B
$1.35M ﹤0.01%
39,216
+2,628
+7% +$84.3K
BOBE
2750
CALL
DELISTED
Bob Evans Farms, Inc.
BOBE
$1.35M ﹤0.01%
26,900

Similar funds

David Shaw's Q1 2014 Portfolio in Review

As of Q1 2014, David Shaw held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

David Shaw deployed $3.3B of net new capital in Q1 2014, opening 596 new positions and adding to 1,359 existing holdings. Its largest new stake was Veren: 1,596,878 shares worth $53.3M.

By sector, the portfolio is most concentrated in Communication Services at 9.3% of assets, up from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $453M trimmed.

  • David Shaw's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
  • David Shaw added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
  • David Shaw's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
  • David Shaw fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
  • David Shaw's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
  • David Shaw opened 596 new positions and closed 795 in Q1 2014.
  • David Shaw's portfolio value fell 4.4% quarter-over-quarter to $70.1B.

Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.